Therapeutic Drug Monitoring for IBD Children on Thioguanine
- PMID: 37346029
- DOI: 10.1097/MPG.0000000000003870
Therapeutic Drug Monitoring for IBD Children on Thioguanine
Comment in
-
Reply to: Therapeutic Drug Monitoring for IBD Children on Thioguanine.J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):e65-e66. doi: 10.1097/MPG.0000000000003871. Epub 2023 Jun 22. J Pediatr Gastroenterol Nutr. 2023. PMID: 37346010 No abstract available.
Comment on
-
Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series.J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):e111-e115. doi: 10.1097/MPG.0000000000003621. Epub 2022 Sep 20. J Pediatr Gastroenterol Nutr. 2022. PMID: 36136124 Free PMC article.
References
-
- Bayouny AB, Jagt JZ, van Wering HM, et al. Safety of thioguanine in pediatric inflammatory bowel disease: a multi-center case series. J Pediatr Gastroenterol Nutr 2022;75:e111–5.
-
- Crouwel F, Buiter HJC, de Boer NK. The thiopurine tale: an unexpected journey. J Crohns Colitis 2022;16:1177–83.
-
- De Boer N, Wilhelm A, van Bodegraven A, Wong DR. Guideline therapeutic drug monitoring thiopurines. Available at: https://tdm-mono-grafie.org/monografie/thiopurines .
-
- Lancaster DL, Patel N, Lennard L, Lilleyman JS. Leucocyte versus erythrocyte thioguanine nucleotide concentrations in children taking thiopurines for acute lymphoblastic leukaemia. Cancer Chemother Pharmacol 2002;50:33–6.
-
- Duley JA, Florin TH. Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides. Review. Ther Drug Monit 2005;27:647–54.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
